American Society of Nuclear Cardiology (ASNC), European Association of Nuclear Medicine (EANM), and American College of Nuclear Medicine (ACNM) have issued a new clinical guideline for 18F-flurpiridaz ...

American Society of Nuclear Cardiology (ASNC), European Association of Nuclear Medicine (EANM), and American College of Nuclear Medicine (ACNM) have issued a new clinical guideline for 18F-flurpiridaz ...

The emerging advantages of positron-emission tomography (PET) myocardial perfusion imaging (MPI) for coronary artery disease (CAD) diagnosis and assessment of cardiovascular event risk has prompted ...

The significantly longer half-life of Flyrcado (109 minutes) allows for it to be manufactured at an offsite pharmacy and delivered as a ready-to-use unit dose. The approval was supported by data from ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved a novel PET radiotracer for evaluation of possible MI and ischemia. The approval is based on ...

Please provide your email address to receive an email when new articles are posted on . PET with the radiotracer 18F flurpiridaz had better sensitivity and similar specificity vs. SPECT in patients ...

A novel PET perfusion radiotracer, 18 F-flurpiridaz, can diagnose coronary artery disease (CAD) in obese patients with a higher sensitivity and specificity compared to 99m Tc-SPECT myocardial ...

NORTH BILLERICA, Mass. & CHALFONT ST GILES, United Kingdom--(BUSINESS WIRE)--Lantheus Medical Imaging, Inc. (“LMI”), a subsidiary of Lantheus Holdings, Inc ...

Cleveland-based University Hospitals Harrington Heart & Vascular Institute has become the first site in Ohio to clinically administer Flyrcado for the detection of coronary artery disease and arterial ...

Furthermore, ischemia may not necessarily be localized to an entire myocardial area as in patients with epicardial coronary stenosis. Indeed myocardial ischemia may be patchily distributed in small ...

The significantly longer half-life of Flyrcado (109 minutes) allows for it to be manufactured at an offisite pharmacy and delivered as a ready-to-use unit dose. The Food and Drug Administration (FDA) ...